Physician profile
May Li Wang
NPI 1790793289
$3,151.26
in general payments reported to CMS, 2019-2025
14 companies · $115 in 2025
The $115 reported for 2025 was more than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $494 · 2021: $390 · 2022: $507 · 2023: $637 · 2024: $1,007 · 2025: $115.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,745 · Travel and Lodging: $15.23.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,744.57 |
| Travel and Lodging | $15.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $715.84 | 2021-2025 | Shingrix, Arexvy, Bexsero |
| Boehringer Ingelheim Pharmaceuticals, INC. | $466.56 | 2019-2024 | Jardiance |
| Astrazeneca Pharmaceuticals LP | $419.21 | 2019-2025 | Farxiga, Airsupra |
| Bayer Healthcare Pharmaceuticals INC. | $348.93 | 2021-2024 | |
| Janssen Pharmaceuticals, INC | $259.99 | 2022-2024 | Xarelto |
| Abbvie INC. | $225.00 | 2019 | |
| Lilly USA, LLC | $137.05 | 2024 | Mounjaro |
| Ironwood Pharmaceuticals, INC | $125.00 | 2024 | |
| Amgen INC. | $124.98 | 2022 | |
| Pfizer INC. | $120.23 | 2023-2024 | |
| Sanofi Pasteur INC. | $94.76 | 2019-2023 | |
| Cranial Technologies, INC | $72.86 | 2021-2025 | Doc Band |
| Agios Pharmaceuticals, INC. | $28.63 | 2024 | Pyrukynd |
| Amarin Pharma, INC. | $12.22 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw May Wang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.